Finance

Beta
Lists
APRE:NASDAQ
Aprea Therapeutics Inc
$0.74
-4.37%
(-0.034) 1D
$0.71
-3.90% (-0.029)
After hours
Closed: Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for APRE...
Open
$0.80
High
$0.80
Low
$0.73
Mkt. cap
9.13M
Avg. vol.
176.12K
Volume
108.95K
52-wk high
$2.22
52-wk low
$0.55
EPS
-$1.54
Beta
1.51
Shares outstanding
12.38M
No. of employees
8
Open
$0.80
High
$0.80
Low
$0.73
Mkt. cap
9.13M
Avg. vol.
176.12K
Volume
108.95K
52-wk high
$2.22
52-wk low
$0.55
EPS
-$1.54
Beta
1.51
Shares outstanding
12.38M
No. of employees
8
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to APRE in the past 3 months
Strong Buy
Buy
3
Hold
0
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for APRE in the last 3 months.
Highest
Current $0.74
$6.00 (+709.28%)
Average
$4.07 (+448.96%)
Lowest
$1.20 (+61.86%)
News stories
From sources across the web
About Aprea Therapeutics Inc
CEO-
Employees8
Founded-
Headquarters-
SectorBiotechnology
Websiteaprea.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
118.11K
1.85K
3.34K
-
Cost of goods sold
1.91M
1.64M
1.01M
-
Cost of revenue
1.91M
1.64M
1.01M
-
Research and development expenses
-
-
-
1.61M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.59M
1.48M
1.64M
1.82M
Operating expense
1.59M
1.48M
1.64M
3.43M
Total operating expenses
3.51M
3.12M
2.65M
3.43M
Operating income
-3.39M
-3.12M
-2.64M
-3.43M
Other non operating income
-
-
77.50K
-
EBT including unusual items
-3.24M
-2.97M
-2.46M
-3.29M
EBT excluding unusual items
-3.24M
-2.97M
-2.46M
-3.29M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3.24M
-2.97M
-2.46M
-3.29M
Net profit margin
-2,742.23%
-160,844.70%
-73,587.95%
-
Earnings per share
-0.53
-0.47
-0.32
-0.22
Interest and investment income
178.03K
150.67K
118.66K
134.78K
Interest expense
-
-
-
-
Net interest expenses
178.03K
150.67K
118.66K
134.78K
Depreciation and amortization charges
-
-
-
-
EBITDA
-3.38M
-3.11M
-2.64M
-3.42M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer